Compounded IV Medications: When Are They Necessary and How Are They Made?

July 15, 2026

Most medications that patients receive at a hospital or pharmacy come in standardized, commercially manufactured forms, a 500mg antibiotic vial, a pre-filled syringe, a fixed-concentration IV bag. These products work well for many patients. But a significant portion of patients receiving IV therapy have clinical needs that commercial products cannot meet: a dose the manufacturer doesn't make, a formulation incompatible with the patient's allergy profile, or a combination of nutrients that must be tailored to individual lab values.


For these patients, compounded IV medications are not optional, they are clinically necessary. Pharmko's sterile compounding services prepare customized IV medications for patients across 22+ states, with every formulation reviewed by a licensed pharmacist and prepared in a USP <797> compliant cleanroom.


What Makes an IV Medication 'Compounded'?


A compounded medication is one that is prepared specifically for an individual patient by a licensed pharmacist, rather than manufactured in bulk by a pharmaceutical company. Compounding involves combining, mixing, or altering ingredients, active pharmaceutical ingredients, diluents, preservatives, to create a final preparation that meets the patient's unique prescription requirements.


For IV therapy specifically, compounding means preparing a sterile preparation, one that is completely free of viable microorganisms and safe to inject or infuse directly into the bloodstream. This requires specialized facilities, equipment, training, and quality systems that go far beyond what a standard retail pharmacy can provide.


Pharmko is exclusively a sterile compounding pharmacy. We do not compound oral medications, topical creams, or non-sterile preparations. Every product we make is intended for intravenous, intraperitoneal, or subcutaneous administration.


When Are Compounded IV Medications Necessary?


The required dose doesn't exist commercially


Pharmaceutical manufacturers produce medications in standardized strengths and volumes based on average patient needs. Pediatric patients, patients with renal or hepatic impairment requiring dose adjustments, or patients whose weight or clinical status falls outside standard ranges may need concentrations or volumes that no commercial product provides. Compounding fills this gap precisely.


The patient has an allergy to a commercial formulation's inactive ingredients


Commercial IV products often contain preservatives, stabilizers, or diluents, sulfites, benzyl alcohol, certain dyes, that some patients cannot tolerate. A compounding pharmacy can prepare an equivalent formulation without the offending ingredient, allowing the patient to receive the therapy safely.


The medication requires individualized nutrient formulation


Total parenteral nutrition (TPN) is the clearest example: every TPN formula must be individually compounded because no commercial product can provide the precise combination of amino acids, dextrose, lipids, electrolytes, vitamins, and trace minerals a specific patient needs. The formula changes as the patient's labs, weight, and clinical status change, making standardization impossible.


The commercial product is unavailable or in shortage


Drug shortages are a persistent reality in the US pharmaceutical supply chain. When a commercially manufactured IV medication becomes unavailable, compounding pharmacies can often prepare an equivalent formulation from available active pharmaceutical ingredients, bridging the gap and maintaining continuity of therapy for patients who cannot wait.


The therapy requires a custom delivery format


Some IV medications require specific pH, osmolarity, or concentration adjustments for compatibility with a patient's IV access device or concurrent medications. A compounding pharmacist reviews compatibility and prepares formulations that are safe and stable for the specific administration route and equipment the patient is using.


How Compounded IV Medications Are Made


Step 1: Prescription review


Every compounded IV medication begins with a valid prescription from a licensed prescriber. Pharmko's pharmacists review the prescription for clinical appropriateness, dosing accuracy, ingredient compatibility, and stability before compounding begins.


Step 2: Ingredient sourcing and verification


Active pharmaceutical ingredients for compounding must come from FDA-registered suppliers and meet USP monograph specifications. Each lot is verified for identity, potency, and purity before use.


Step 3: Sterile preparation in a controlled environment


Preparation occurs in an ISO Class 5 laminar airflow workbench or biological safety cabinet, located within a buffer room that meets ISO Class 7 air quality standards. Pharmacy technicians follow validated, written procedures for each preparation type, using aseptic technique to prevent contamination at every step.


Step 4: Pharmacist verification and release


A licensed pharmacist performs a final check of every preparation, verifying appearance, volume, labeling, and documentation, before the product is released. High-risk or complex preparations may undergo sterility testing with defined beyond-use dates based on test results.


Step 5: Cold-chain delivery


Most compounded IV medications require refrigeration. Pharmko uses validated cold-chain packaging and delivery logistics to ensure products arrive within their stability windows and remain temperature-controlled until the patient uses them.


Quality Standards That Matter


Not all compounding pharmacies operate at the same standard. The relevant quality benchmarks for sterile compounding are:


  • USP <797> compliance, the national standard for sterile compounding environments, personnel, and processes. Our guide on USP <797> and USP <800> explains what compliance means in practice
  • ACHC accreditation, independent third-party verification that Pharmko meets clinical quality standards for home infusion and sterile compounding
  • State pharmacy board licensure, Pharmko is licensed in every state where we serve patients
  • Environmental and personnel monitoring, documented air and surface sampling, personnel gowning competency assessments, and media fill testing at defined intervals


For a foundational overview of what sterile compounding is and how it differs from retail pharmacy, see our guide on what is sterile compounding for IV therapy.


Contact Pharmko about compounded IV medications: 1-877-540-2003


home infusion therapy Pennsylvania
July 14, 2026
Pharmko provides home infusion therapy across Pennsylvania, IV antibiotics, IVIG, TPN, biologics, and specialty medications. Licensed, ACHC accredited, and available 24/7 statewide.
Home Infusion Therapy in New Jersey
July 14, 2026
Pharmko provides home infusion therapy across New Jersey, IV antibiotics, IVIG, TPN, IDPN, biologics, and more. Licensed, ACHC accredited, and available 24/7 statewide.
Renal dietitian reviewing albumin labs for a peritoneal dialysis patient
July 10, 2026
When to consider IPN for peritoneal dialysis patients with low albumin: clinical criteria, the stepwise nutrition approach, and the referral process.
Nephrologist reviewing dialysis nutrition options for an ESRD patient
July 10, 2026
IPN vs. IDPN explained: how each parenteral nutrition therapy works, who qualifies, and how to choose the right option for ESRD dialysis patients.
How Home Infusion Reduces Hospital Readmissions
July 10, 2026
Home infusion therapy is associated with lower hospital readmission rates, fewer complications, and significant cost savings. Review the clinical evidence and learn how Pharmko supports discharge planning teams.
Primary Immune Deficiency and IVIG: A Guide for Newly Diagnosed Patients
July 8, 2026
Newly diagnosed with primary immune deficiency? Learn how IVIG therapy works, what to expect from your first infusions, how home IVIG is coordinated, and how Pharmko supports PID patients long-term.
Why They Matter and How Pharmko Customizes Your Formula
July 8, 2026
Trace minerals are essential components of every TPN formula. Learn what trace elements are included in parenteral nutrition, why each matters clinically, and how Pharmko pharmacists individualize your formula.
How to Choose a Home Infusion Pharmacy
June 26, 2026
Not all home infusion pharmacies are equal. Learn the 7 key questions to ask before choosing a specialty pharmacy, accreditation, clinical support, state licensing, and more.
Home Infusion for Lupus: Benlysta and Biologic Therapy Options for SLE
June 25, 2026
Learn how home infusion therapy works for lupus (SLE), including Benlysta (belimumab) and other IV biologics, who qualifies for home treatment, and how Pharmko supports ongoing lupus care across 22+ states.
IPN Therapy for Peritoneal Dialysis Patients
June 25, 2026
Learn how intraperitoneal nutrition (IPN) works for malnourished peritoneal dialysis patients, who qualifies, how amino acids are delivered during PD exchanges, and how Pharmko coordinates IPN therapy.
Show More